Aurobindo Pharma gets nod to sell generic version of Augmentin

24 Dec 2011 Evaluate

Aurobindo Pharma has received an approval from the US Food & Drug Administration (USFDA) to sell its generic version of GlaxoSmithKline’s Augmentin in the world’s largest drug market. The administrator has given nod to sell the drug in three strengths.

Augmentin is used to treat many different infections caused by bacteria, such as sinusitis, pneumonia, ear infections, bronchitis, urinary tract infections, and infections of the skin.

Recently, Aurobindo pharma major had secured final approval from the US Food & Drug Administration to manufacture and market Gabapentin Tablets USP 600mg and 800mg.

Aurobindo Pharma, headquartered at Hyderabad, India, manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s manufacturing facilities are approved by several leading regulatory agencies like USFDA, UKMHRA, WHO, Health Canada, MCC South Africa, TGA Australia, ANVISA Brazil.

Aurobindo Pharma Share Price

1223.65 3.45 (0.28%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.